Literature DB >> 8568824

Synthesis and antitumor evaluation of a highly potent cytotoxic DNA cross-linking polyamine analogue, 1,12-diaziridinyl-4,9-diazadodecane.

Y Li1, J L Eiseman, D L Sentz, F A Rogers, S S Pan, L T Hu, M J Egorin, P S Callery.   

Abstract

A diaziridinylspermine analogue, 1,12-diaziridinyl-4,9-diazadodecane (NSC-667005), was synthesized as a bisalkylating agent with a polyamine backbone. DNA cross-linking was detected in the reaction of linearized pBR322 DNA with 1,12-diaziridinyl-4,9-diazadodecane at concentrations comparable with that required for cross-linking by two nitrogen mustard drugs, mechlorethamine and melphalan. A significant increase in life span of female CD2F1 mice bearing L1210 murine leukemia was observed after intravenous administration of 1,12-diaziridinyl-4,9-diazadodecane in doses of less than 2.7 mg/kg, given on days 1, 5, and 9 of treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8568824     DOI: 10.1021/jm9500885

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Probing tRNA interaction with biogenic polyamines.

Authors:  Amin Ahmed Ouameur; Philippe Bourassa; Heidar-Ali Tajmir-Riahi
Journal:  RNA       Date:  2010-08-20       Impact factor: 4.942

2.  Novel synthetic polyamines are effective in the treatment of experimental microsporidiosis, an opportunistic AIDS-associated infection.

Authors:  Cyrus J Bacchi; Louis M Weiss; Schenella Lane; Benjamin Frydman; Aldonia Valasinas; Venodhar Reddy; Jerry S Sun; Laurence J Marton; Imitiaz A Khan; Magali Moretto; Nigel Yarlett; Murray Wittner
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

3.  Binding of the biogenic polyamines to deoxyribonucleic acids of varying base composition: base specificity and the associated energetics of the interaction.

Authors:  Ayesha Kabir; Gopinatha Suresh Kumar
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.